๋ฉ”์ธ ์ฝ˜ํ…์ธ ๋กœ ๊ฑด๋„ˆ๋›ฐ๊ธฐ
์ฆ๋ก€ #2
1/28
ํ™˜์ž ์ •๋ณด: 2 ์„ธ, ์—ฌ์„ฑ
์ ์‘์ฆ: ์„ฑ์žฅ ๋ถ€์ „

์ฆ๋ก€ #2

๋ฌด๋ฃŒ
๋ชจ๋‘ ๋ณด๊ธฐ

์†Œ๊ฒฌ

CT (MRI ์ˆ˜์ผ ํ›„ ์‹œํ–‰)

  • ํ์‡„์„ฑ ์ˆ˜๋‘์ฆ ๋ฐ ๋‡Œ์‹ค์ฃผ์œ„ ๋ถ€์ข…์„ ๋™๋ฐ˜ํ•œ ์ œ3๋‡Œ์‹ค๋กœ ํ™•์žฅ๋˜๋Š” ์•ˆ์žฅ์œ„ ์ €์Œ์˜ ์ข…๊ดด
  • ์ข…๊ดด ๋‚ด ์„ํšŒํ™” ์—†์Œ
  • ์šฐ์ธก ์ „๋‘๋ถ€ ์ ‘๊ทผ ๋‡Œ์‹ค ๋‹จ๋ฝ ์นดํ…Œํ„ฐ๊ฐ€ ์ข…๊ดด์— ์ธ์ ‘ํ•œ ์ œ3๋‡Œ์‹ค์— ์œ„์น˜

MRI

  • ๋šœ๋ ทํ•œ T2 ๊ณ ์‹ ํ˜ธ๊ฐ•๋„, ๊ท ์ผํ•˜๊ฒŒ ์กฐ์˜์ฆ๊ฐ•๋˜๋Š” ์•ˆ์žฅ์œ„ ์ข…๊ดด๋กœ, ์ƒ๋ฐฉ์œผ๋กœ ์ œ3๋‡Œ์‹ค๋กœ ํ™•์žฅ๋˜๊ณ , ํ›„๋ฐฉ์œผ๋กœ ๊ต์ „์กฐ๋กœ ํ™•์žฅ๋˜์–ด ๊ต์— ๊ฒฝ๋ฏธํ•œ ์••๋ฐ• ํšจ๊ณผ๋ฅผ ๋ณด์ด๋ฉฐ, ์‹œ์‹ ๊ฒฝ ๊ต์ฐจ, ์–‘์ธก ์ƒ์ƒ๋Œ๊ธฐ ๋‚ด๊ฒฝ๋™๋งฅ, ์›์œ„ ๊ธฐ์ €๋™๋งฅ, ์–‘์ธก ํ›„๋Œ€๋‡Œ๋™๋งฅ ๋ฐ ์ƒ์†Œ๋‡Œ๋™๋งฅ ๊ทผ์œ„๋ถ€๋ฅผ ๋‘˜๋Ÿฌ์‹ธ๊ณ  ์žˆ์Œ
  • ๋Œ€์‘ํ•˜๋Š” ํ™•์‚ฐ ์ œํ•œ ๋˜๋Š” ์žํ™”์œจ ์ธ๊ณต๋ฌผ ์—†์Œ
  • ์ œ3๋‡Œ์‹ค ์ˆ˜์ค€์—์„œ ๋‡Œ์‹ค์ฃผ์œ„ ๋ถ€์ข…์„ ๋™๋ฐ˜ํ•œ ํ์‡„์„ฑ ์ˆ˜๋‘์ฆ

์ฃผ์„์ด ์žˆ๋Š” ์ด๋ฏธ์ง€ ๋ฐ ์ผ๋Ÿฌ์ŠคํŠธ

Markedly T2 hyperintense mass centered in the suprasellar cistern (red arrows).

Markedly T2 hyperintense mass centered in the suprasellar cistern (red arrows).

Corresponding avid enhancement (red arrows). The mass encases multiple vascular structures and extends into the prepontine cistern with mass effect on the pons.

Corresponding avid enhancement (red arrows). The mass encases multiple vascular structures and extends into the prepontine cistern with mass effect on the pons.

์ง„๋‹จ

์ ์•ก์–‘ ๋ชจ์–‘์„ธํฌ ์„ฑ์ƒ์„ธํฌ์ข…

์ฃผ์š” ์˜์ƒ ์†Œ๊ฒฌ

  • ์ด ์ข…์–‘์€ ์•ˆ์žฅ์œ„ ์˜์—ญ์— ๊ฐ•ํ•œ ํ˜ธ๋ฐœ ๋ถ€์œ„๋ฅผ ๋ณด์ž…๋‹ˆ๋‹ค
  • ์ ์•ก์–‘ ์„ฑ๋ถ„์œผ๋กœ ์ธํ•ด ์ด ์ข…์–‘์€ ์ผ๋ฐ˜์ ์œผ๋กœ ๋งค์šฐ T2 ๊ณ ์‹ ํ˜ธ๊ฐ•๋„์ด๋ฉฐ ์ œํ•œ๋ณด๋‹ค๋Š” ์ด‰์ง„๋œ ํ™•์‚ฐ์„ ๋ณด์ž…๋‹ˆ๋‹ค
  • ์กฐ์˜์ฆ๊ฐ• ์–‘์ƒ์€ ๋‹ค์–‘ํ•ฉ๋‹ˆ๋‹ค(์ด ์ข…์–‘์ด ๊ท ์ผํ•˜๊ฒŒ ์กฐ์˜์ฆ๊ฐ•๋˜์ง€ ์•Š๊ณ  ๋‚ด๋ถ€ ์ถœํ˜ˆ์„ ๋ณด์ด๋Š” ๊ฒฝ์šฐ, ๋™๋งฅ๋ฅ˜๊ฐ€ ์ค‘์š”ํ•œ ๊ฐ๋ณ„ ๊ณ ๋ ค ์‚ฌํ•ญ์ž…๋‹ˆ๋‹ค)
  • ๋ชจ์–‘์„ธํฌ ์„ฑ์ƒ์„ธํฌ์ข…๋ณด๋‹ค ๋‚ด๋ถ€ ์ถœํ˜ˆ์ด ๋” ํ”ํ•ฉ๋‹ˆ๋‹ค

๊ฐ๋ณ„์ง„๋‹จ

  • ๋ชจ์–‘์„ธํฌ ์„ฑ์ƒ์„ธํฌ์ข… - PMA์™€ ๋‹ฌ๋ฆฌ, ๋ชจ์–‘์„ธํฌ ์„ฑ์ƒ์„ธํฌ์ข…์€ 2์„ธ ๋ฏธ๋งŒ ์†Œ์•„์—์„œ ๋“œ๋ฌผ๊ณ  ๋‚ด๋ถ€ ์ถœํ˜ˆ์ด ์ ์Šต๋‹ˆ๋‹ค
  • ๋‘๊ฐœ์ธ๋‘์ข… - PMA์™€ ๋‹ฌ๋ฆฌ, ์†Œ์•„์—์„œ ํ”ํžˆ ์„ํšŒํ™”๋ฅผ ๋™๋ฐ˜ํ•ฉ๋‹ˆ๋‹ค
  • ๋ฐฐ์•„์ข… - ์•ˆ์žฅ์œ„ ์˜์—ญ์€ ์ด ๊ฐ•ํ•˜๊ฒŒ ์กฐ์˜์ฆ๊ฐ•๋˜๋Š” ์ข…์–‘์˜ ๋‘ ๋ฒˆ์งธ๋กœ ํ”ํ•œ ์œ„์น˜์ด๋ฉฐ(์†ก๊ณผ์ฒด ์˜์—ญ์ด ๊ฐ€์žฅ ํ”ํ•œ ์œ„์น˜), PMA๋ณด๋‹ค T2 ๊ณ ์‹ ํ˜ธ๊ฐ•๋„๊ฐ€ ์ ์€ ๊ฒฝํ–ฅ์ด ์žˆ๊ณ  ๋‚จ์„ฑ ํ™˜์ž์—์„œ ํ›จ์”ฌ ๋” ํ”ํ•ฉ๋‹ˆ๋‹ค

๊ณ ์ฐฐ

  • ์ ์•ก์–‘ ๋ชจ์–‘์„ธํฌ ์„ฑ์ƒ์„ธํฌ์ข…(PMA)์€ ์˜์œ ์•„๊ธฐ๋ถ€ํ„ฐ ์„ฑ์ธ๊ธฐ๊นŒ์ง€ ๋„“์€ ์—ฐ๋ น๋Œ€์—์„œ ๋ฐœ์ƒํ•ฉ๋‹ˆ๋‹ค
  • ์‹ ๊ฒฝ์„ฌ์œ ์ข…์ฆ 1ํ˜•๊ณผ์˜ ์ž ์žฌ์  ์—ฐ๊ด€์„ฑ์ด ์žˆ์Šต๋‹ˆ๋‹ค

ํ•ต์‹ฌ ํฌ์ธํŠธ

  • ๋šœ๋ ทํ•œ T2 ๊ณ ์‹ ํ˜ธ๊ฐ•๋„๋ฅผ ๋ณด์ด๋Š” ์กฐ์˜์ฆ๊ฐ• ์•ˆ์žฅ์œ„ ์ข…๊ดด๋ฅผ ๋ณด๋ฉด ์ ์•ก์–‘ ๋ชจ์–‘์„ธํฌ ์„ฑ์ƒ์„ธํฌ์ข…์„ ์ƒ๊ฐํ•˜์‹ญ์‹œ์˜ค
  • ๋ชจ์–‘์„ธํฌ ์„ฑ์ƒ์„ธํฌ์ข…๊ณผ ๋น„๊ตํ•˜์—ฌ, ์ ์•ก์–‘ ๋ชจ์–‘์„ธํฌ ์„ฑ์ƒ์„ธํฌ์ข…์€ ๋งค์šฐ ์–ด๋ฆฐ ์†Œ์•„์—์„œ ๋ฐœ์ƒํ•  ๊ฐ€๋Šฅ์„ฑ์ด ๋†’๊ณ  ์ถœํ˜ˆ ๋™๋ฐ˜ ๊ฐ€๋Šฅ์„ฑ์ด ๋” ๋†’์Šต๋‹ˆ๋‹ค

์ฐธ๊ณ ๋ฌธํ—Œ

  • Linscott LL, Osborn AG, Blaser S, Castillo M, Hewlett RH, Wieselthaler N, Chin SS, Krakenes J, Hedlund GL, Sutton CL. Pilomyxoid astrocytoma: expanding the imaging spectrum. AJNR Am J Neuroradiol 2008; 29 (10): 1861-1866.

    • ์‚ฌ์ดํŠธ ํ”ผ๋“œ๋ฐฑ

    ์—ฌ๋Ÿฌ๋ถ„์˜ ํ”ผ๋“œ๋ฐฑ์€ CaseStacks ๊ฐœ์„ ์— ๋„์›€์ด ๋ฉ๋‹ˆ๋‹ค. ์˜๊ฒฌ, ์ œ์•ˆ ๋˜๋Š” ๋ฐœ์ƒํ•œ ๋ฌธ์ œ๋ฅผ ๊ณต์œ ํ•ด ์ฃผ์„ธ์š”.

    /5
    ํ”ผ๋“œ๋ฐฑ์„ ๋ณด๋‚ด์ฃผ์…”์„œ ๊ฐ์‚ฌํ•ฉ๋‹ˆ๋‹ค. ์†Œ์ค‘ํžˆ ๋ฐ˜์˜ํ•˜๊ฒ ์Šต๋‹ˆ๋‹ค.